Karim Dorgham

机构：Centre National de la Recherche Scientifique, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Pitié-Salpêtrière Hospital, Centre d'Immunologie et des Maladies Infectieuses · ORCID：0000-0001-9539-3203

发表论文 151 篇 · 总被引 12384 次 · h-index 40

代表论文

• The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies (2022 · Proceedings of the National Academy of Sciences · 被引 199)
• Cytokines in New‐Onset Refractory Status Epilepticus Predict Outcomes (2023 · Annals of Neurology · 被引 122)
• Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α (2022 · Annals of the Rheumatic Diseases · 被引 88)
• Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs (2022 · Science Immunology · 被引 79)
• Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults (2022 · Journal of the American College of Cardiology · 被引 52)
• Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination (2024 · JAMA Network Open · 被引 33)